InsideTrading SEC Form 4 insider trades
← All clusters
CRDF

Cardiff Oncology, Inc.

Moderate buying: $800.0K bought (counted up to $5.0M); 8 distinct insiders. Holding it back: largest buyer: Erlander Mark (CEO), 74% of the dollars.

More than 30% below the insider price

66
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. 60–79 · moderate buying
-194.9%
Since the cluster formed, vs benchmark (-64.1% raw)

Score, not a recommendation.

Total bought$810.0K8 Form 4 purchases
Distinct insiders8open-market buyers
Insiders' average price$1.36-46.7% to the latest close
Cluster window2020-05-11 → 2020-05-14closed

Price and insider purchases

Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.

Loading price history…

How the score adds up

How each input is counted →
Points each input adds to the score, and how much of the points it could give it has
Input Strength Points
$800.0K bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. 71% +47
8 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. 90% +13
A CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. 100% +10
Stock 67% below its 1-year high (counted up to 30%)How far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. 100% +5
3 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. 95% +0
Routine or plan purchases: 0% of the dollarsThe share of the dollars in routine or plan purchases (a Rule 10b5-1 plan, dividend reinvestment, a regular cadence). All of it routine would take off 5.6 points. 100% +0
Largest buyer: Erlander Mark (CEO), 74% of the dollarsThe share of the dollars bought by the largest buyer. Buying spread evenly keeps the points; one buyer paying for everything takes off 12.7. 30% -9
Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast.66

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Transactions

8 Form 4 trades · 8 insiders Download CSV Up to 5,000 rows
Purchases in this cluster, grouped by insider, largest first
Date InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. Role Shares Price Value Filing
2020-05-11 PACE GARY W 13 purchases with a 63-day result · median +10.7% Director 447,761 $1.34 $600.0K SEC filing for PACE GARY W (opens in a new tab)
2020-05-14 White Lale history of White Lale's purchases Director 69,930 $1.43 $100.0K SEC filing for White Lale (opens in a new tab)
2020-05-14 Markin Rodney S 3 purchases with a 63-day result · median -27.9% Director 20,979 $1.43 $30.0K SEC filing for Markin Rodney S (opens in a new tab)
2020-05-14 JACOB GARY S history of JACOB GARY S's purchases Director 17,483 $1.43 $25.0K SEC filing for JACOB GARY S (opens in a new tab)
2020-05-14 ADAMS THOMAS PHD history of ADAMS THOMAS PHD's purchases Director 13,986 $1.43 $20.0K SEC filing for ADAMS THOMAS PHD (opens in a new tab)
2020-05-14 Armitage James O 3 purchases with a 63-day result · median -8.6% Director 10,490 $1.43 $15.0K SEC filing for Armitage James O (opens in a new tab)
2020-05-14 BRANCACCIO JOHN P 3 purchases with a 63-day result · median -11.3% Director 6,993 $1.43 $10.0K SEC filing for BRANCACCIO JOHN P (opens in a new tab)
2020-05-14 Erlander Mark 3 purchases with a 63-day result · median +12.0% CEO 6,993 $1.43 $10.0K SEC filing for Erlander Mark (opens in a new tab)
Total $810.0K

Other buying runs at CRDF

A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.

After this buying run became a cluster, vs benchmark: 21 days +45.3% (+52.8% raw)63 days +175.1% (+193.8% raw)126 days +739.3% (+774.6% raw)

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2024-12-11 → 2024-12-18 3 $1.0M 48 -31.7% (-29.0% raw)-16.2% (-22.9% raw)-32.5% (-37.1% raw) closed
2022-09-15 → 2022-09-19 5 $365.4K 49 -2.0% (-3.0% raw)-19.0% (-19.5% raw)+2.3% (+3.0% raw) closed
2021-03-04 → 2021-03-26 7 $298.5K 61 -17.9% (-15.1% raw)-32.3% (-28.0% raw)-32.9% (-32.1% raw) closed
2018-06-08 → 2018-06-20 3 $51.0K 34 -12.3% (-19.6% raw)-27.9% (-27.8% raw)-34.6% (-33.3% raw) closed
2016-12-14 → 2016-12-19 3 $71.3K 28 ––– closed